PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
173.56%
Revenue growth above 1.5x 6247.T's 30.17%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
81.63%
Gross profit growth above 1.5x 6247.T's 36.71%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
253.58%
EBIT growth above 1.5x 6247.T's 104.02%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
299.78%
Operating income growth similar to 6247.T's 293.85%. Walter Schloss would assume both share comparable operational structures.
419.93%
Net income growth above 1.5x 6247.T's 33.96%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
419.48%
EPS growth above 1.5x 6247.T's 33.95%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
419.48%
Diluted EPS growth above 1.5x 6247.T's 33.95%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-84.40%
Negative 10Y revenue/share CAGR while 6247.T stands at 0.17%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
14.43%
5Y revenue/share CAGR under 50% of 6247.T's 31.16%. Michael Burry would suspect a significant competitive gap or product weakness.
67.84%
3Y revenue/share CAGR above 1.5x 6247.T's 18.24%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
105.75%
Positive 10Y CAGR while 6247.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-28.00%
Negative 5Y net income/share CAGR while 6247.T is 171.40%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
253.81%
3Y net income/share CAGR above 1.5x 6247.T's 47.32%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-64.77%
Negative equity/share CAGR over 10 years while 6247.T stands at 31.37%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
138.62%
5Y equity/share CAGR above 1.5x 6247.T's 23.81%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
24.93%
3Y equity/share CAGR above 1.5x 6247.T's 4.97%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
128.89%
AR growth well above 6247.T's 2.59%. Michael Burry fears inflated revenue or higher default risk in the near future.
-58.42%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.52%
Asset growth above 1.5x 6247.T's 0.68%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
8.07%
BV/share growth above 1.5x 6247.T's 1.48%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-4.53%
We’re deleveraging while 6247.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-18.56%
Our R&D shrinks while 6247.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
142.69%
SG&A growth well above 6247.T's 1.19%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.